12 Arijitd Medicine Case Records

:: PART–A :: Sl. Hospital No No. . 1 2 3 4 5 6 7 8 9 10 11 12

1749/03 018957/0 3

Ag Cough Com. C Na e Occupatio D H N. & hest Fv me (Yr. n ysp. Dr Ex mpt. Stv Sex pain ) y p KM 30

H/M Cultivator

+

+

+

–

–

LG

+

DL

H/F

+

+

–

–

+

LG

–

27

HW

H/M Teacher

+

+

–

–

–

LG

+

—

H/M Cultivator

+

+

–

+

–

LG

–

—

4969/03 048885/0 3 141459/0 3

MK 17

H/F

+

+

–

+

–

LG

+

KD

61

–

+

+

+

+

LG

–

KP

55

H/M Business Shop M/M Keeper

–

+

+

+

–

LG

–

—

10597/03 112662/0 3 113992/0 3 146388/0 3 128114/0 3 149884/0 3 233143/0 3

SH

21

H/M Student

+

+

+

+

–

LG

–

—

KC

15

H/F

Student

+

+

+

+

+

LG

+

—

RH

48

H/F

service

+

+

+

+

–

LG

+

—

KP

20

H/M student

+

+

+

+

–

LG

–

—

NN 25

–

+

+

+

–

–

Leg swl

+

–

+

–

–

LG H G

+

— Joint pain palpitati on palpitati on

Student

TK

28

LM

16

H/M student

+

+

+

–

–

LG

–

15 16237/03 005022/0 16 3

PG

58

+

+

+

–

–

LG

–

KP

44

H/M cultivator T/G H/M labour

+

+

+

–

+

–

17

RK

65

H/F

+

–

+

–

–

LG H G

PK

14

abd. Swl loss of apt

9509/03 KN 32 019859/3 0 MM 48

H/M service T/G H/M labour

13

Others

543/04 198974/0 18 3 066744/0 19 4

18

H/M student

+

+

–

–

–

LG

+

NN 26

H/M service

+

–

–

–

–

LG

–

—

20 21

PL RF

M/M teacher H/M T/G

+ –

– –

+ –

– –

– –

LG LG

– –

— puff.

873/04 1282/03

32 30

rickpuller

–

— palpitati on

— loss of apt

Puls R Lymp Wt Bp e esp Cy In E C Neck h (K (mmH (/mi (/mi n d d lub Vein Glan g) g) n) n) d 120/7 68 78 0 18 – – – – NE — 120/6 50 85 8 20 – – – – NE — 130/8 70 90 5 22 – – – – NE — 120/7 54 55 4 18 – – – – NE — 112/7 48 63 8 36 – – – – NE — 130/9 Eng/P 58 78 6 20 – – + – ul — 120/6 52 80 8 24 – – – – NE — 124/9 50 98 8 18 – – – – NE — 116/1 49 84 6 20 – – – – NE — 126/7 48 76 4 20 + – – – NE — 110/7 58 78 0 26 – – – + NE — 120/8 Eng/P 56 86 6 16 – – + – ul — 120/7 52 88 0 24 – – – – NE L Scl 25 130/8 6 100 0 18 – – – – NE — 116/8 Eng/P 43 96 0 20 – – + – ul — 120/5 51 78 6 16 – – – – NE — 120/7 L 38 96 8 18 – – – + NE CVL 120/8 45 94 6 26 – – – – NE — 130/8 Eng/P 52 91 0 18 + – + – ul — 124/8 51 105 9 22 – – – – NE — 50 88 130/7 26 – – – – NE —

Abdomen Rsp. Sys. As c Other PE ( R ) – NAD PE(BL ) + Sp 2+ PE(L) PE ( R ) PE ( R ) PE(BL ) PE(BL ) PE ( R )

CVS

NAD Crr, PHTN, Asc

– NAD

NAD

– NAD

NAD

– NAD NAD Liv 4f Sp – 1f MR+MS Crr, PHTN, + NAD Asc – NAD

NAD

PE(L) – NAD PE ( R ) – NAD

NAD

PE(L) PE(BL ) PE ( R ) PE ( R ) PE(BL ) PE(BL )

– NAD

NAD

– Liv 3f

MR+MS+TR

– NAD

NAD

– NAD

NAD

– liv 2f

DCM+Mr+Tr

– liv 3f

MR+MS+TR

NAD

PE(L) – NAD PE ( R ) – NAD

NAD

PE(L) – NAD PE ( R ) – NAD PE(L) – NAD

Neph C, Asc

NAD

NAD NAD

CN S NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA

 CAS E RECOR DS 

SK

NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD

1

labour 22 23 24 25 26 27

100347/0 3 100447/0 3 016244/0 3 0100556/ 03 115037/0 3 137732/0 3

Face

GH 16

H/M Student

+

+

–

–

+

LG

–

JH

30

M/M Cultivator

+

+

+

–

–

LG

–

LD

35

H/F

HW

+

+

–

–

–

AL

35

M/M Business

–

–

+

–

–

LG H G

BK

55

H/M Business

+

–

–

–

–

LG

–

+

–

+

–

–

LG

–

+

–

–

–

–

LG

–

GH 25

–

— abd. Swl

43

96

46

85

— loss of apt

47

96

52

78

— puff. Face

44

75

50

85

—

52

96

28 03886/03

YL

38

H/M Student T/G H/M labour

29 01756/03

GL

13

H/M Student

+

–

–

–

–

LG

–

—

58

85

H/M service

+

–

+

+

–

+

—

63

84

H/M Cultivator

+

–

+

+

–

LG H G

–

—

46

75

H/M Cultivator

+

–

+

+

–

LG

–

—

41

73

H/F

+

–

+

–

–

LG

–

—

40

72

+

–

+

–

–

LG

–

—

43

95

+

–

+

–

–

LG

–

44

84

30 11295/03 UM 25 139885/0 31 3 EL 30 006922/0 32 3 NH 75 244146/0 33 3 YH 26 079652/0 34 3 IG 49

HW

H/F

35 06592/04

BH

83

HW retd. H/M Service

36 10239/04 126224/0 37 4

GP

50

M/M Cultivator

+

+

+

–

–

LG

+

—

42

65

FP

45

H/M Business

+

+

–

–

–

LG

–

—

52

85

38 01365/04

DB 13

H/M Student

+

–

+

–

–

LG

–

82

39 04369/04 106526/0 40 4

EH

50

H/F

HW

+

–

–

–

–

LG

–

— 51 palpitati on 60

SZ

17

H/F

Teacher

+

–

+

–

–

LG

–

wt loss

—

58

81 76

8 130/9 0 120/8 5 126/7 4 110/7 0 120/8 6 120/7 0 130/8 0 116/8 0 120/5 6 120/7 8 120/7 0 120/6 8 130/8 5 120/7 4 112/7 8 120/7 0 130/8 0 116/8 0 120/7 8

30

– – –

+

NE

—

28

– – –

–

NE

—

29

– – –

–

NE

—

24

– – –

–

NE

—

38

+ – –

–

NE

—

30

– – –

–

NE

20

– – –

–

NE

28

– – –

–

NE

25

– – –

–

NE

26

– – –

–

NE

38

– – –

–

NE

32

– – –

–

NE

26

– – –

–

NE

28

– – –

–

NE

—

29

– – –

–

NE

—

30

– – –

–

NE

—

34

– – –

–

NE

—

34

– – –

–

NE

—

29

– – –

–

NE

—

Total Serum Protein (gm/dl)

Serum Albumin (mg%)

PE ( R ) – NAD PE(BL liv 1f ) + sp2f

NAD Crr, PHTN, Asc

PE(L) – NAD PE ( R ) – NAD

NAD

NAD

—

PE(L) – NAD PE ( R ) – NAD

—

– NAD

NAD

– NAD

NAD

– NAD

NAD

– NAD

NAD

– NAD

NAD

– NAD

NAD Peri card effusion

PE(L) PE ( R — ) R PE ( R Cev ) PE ( R — ) PE ( R L Scl ) PE ( R L Scl ) PE ( R — )

– liv 3f

NAD

NAD

PE(L) – NAD PE ( R ) – NAD PE(BL liv 1f ) – sp2f

NAD

PE(L) – NAD PE ( R ) – NAD PE(BL ) – liv 2f

NAD

NAD Crr, PHTN, Asc

NAD DCMP

D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D NA D

NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD

:: PART–B :: Sl. ESR No. Hb% (AEFH )

BLOOD DLC TLC

Po Ly M

E

Sputum B

BT (m–sec)

CT (m–sec)

Urine

Stool

AFB

Im Cell

Bact.

Serum LDH (U/L)

PA View Chest X–ray

USG & Ecocardiography

 CAS E RECOR DS 

2

1 2 3 4 5 6 7 8 9 10 11 12 13 14

60 65 80 78 74 56 65 69 78 75 64 62 73 80

56 48 102 64 102 20 75 50 140 100 40 18 54 48

15

60

24

16 17 18 19 20

65 69 75 71 65

30 40 104 38 110

21 22

63 78

23

8640 5424 8760 6780 11760 8920 7960 6890 10604 8640 8640 7830 11204 10524

1 1 0 0 0 0 0 0 0 0 0 0 0 0

2 1 0 0 2 1 0 2 4 2 1 1 0 6

1 1 1 1 0 0 0 0 0 0 0 0 0 0

5068 45 18 0

1

0 2min 30 sc

0 0 0 2 1

8 2 6 2 1

0 0 0 0 0

30 38

10620 56 45 1 7630 45 60 2

1 1

63

30

4680 66 65 0

0

24

79

84

13800 84 58 0

2

25

80

58

5400 69 52 0

4

26

73

54

6800 45 52 0

0

27 28 29 30 31

75 63 69 78 80

30 56 52 54 40

9904 7350 5640 8646 7540

0 0 0 1 1

0 0 0 2 0

0 2min 30 sc 0 2min 30 sc 1 min 30 0 sc 1 min 30 0 sc 1 min 30 0 sc 1 min 30 0 sc 1 min 30 0 sc 0 3 min 0 3 min 0 3 min 0 3 min

32

60

48

7400 56 46 2

1

0

33

69

98

8654 52 56 1

1

0

34 35

64 63

10 40

9400 46 58 0 6450 63 54 0

1 0

0 0

8600 6450 10420 6500 6480

58 48 58 64 75 74 58 45 56 45 75 53 60 62

53 75 68 69 56

56 35 62 56 45

36 50 42 46 50 44 36 50 42 38 20 40 38 54

56 32 38 43 38

16 18 20 56 54

2min 2min 2min 2min 2min 2min 2min 2min 2min 2min 2min 2min 2min 2min

2min 2min 2min 2min 2min

30 30 30 30 30 30 30 30 30 30 30 30 30 30

30 30 30 30 30

sc sc sc sc sc sc sc sc sc sc sc sc sc sc

sc sc sc sc sc

2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 1 min 30 sc alb+ 1 min 30 sc NAD 3 min NAD 3 min NAD 3 min alb++ 3 min NAD alb++ 4 min + 2min 30 sc NAD

NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD NAD

– – + – – – – – + – – – + –

– – – – – – – Adc+ – – Adc+ – – –

– – – – – – – – – – – – – –

6.20 6.25 6.30 6.00 6.17 7.10 6.15 6.28 6.19 6.70 6.23 6.50 5.80 6.14

4.36 4.29 4.44 4.24 4.46 4.23 4.27 4.15 4.48 4.45 4.37 4.29 4.28 4.31

330 340 329 341 320 342 345 333 345 340 332 331 328 331

PE ( R ) kochs RUZ PE(BL) PE(L) PE ( R ) Mass PE ( R ) Kochs RUZ PE(BL) PE(BL) PE ( R ) PE(L) Kochs LUZ PE ( R ) PE(L) Mass PE(BL) PE ( R ) PE ( R )

NAD Crr, PHTN, Asc NAD NAD NAD MR+MS Crr, PHTN, Asc NAD NAD NAD NAD MR+MS+TR NAD NAD

NAD

–

–

–

6.16

4.50

337

PE(BL)

DCM+Mr+Tr

NAD NAD NAD NAD NAD

– – + – –

– – – – –

– – – – –

5.60 5.63 5.70 5.75 5.58

3.80 3.98 4.05 4.09 3.97

875 871 865 879 888

PE(BL) PE(L) PE ( R ) Kochs RUZ PE(L) PE ( R ) Kochs RUZ

MR+MS+TR NAD NAD Neph C, Asc NAD

NAD NAD

– –

– –

– –

5.56 5.72

3.93 3.90

815 885

PE(L) PE ( R ) Mass

NAD NAD

3min

NAD

NAD

–

–

–

5.75

3.91

886

PE(BL)

Crr, PHTN, Asc

3min 1min 40 sec

NAD

NAD

–

–

Str+

6.83

4.57

624

PE(L) Consd

NAD

NAD

NAD

–

–

–

6.89

4.63

617

PE ( R ) Kochs RUZ

NAD

NAD

–

–

–

5.20

4.10

720

PE(L)

NAD

NAD NAD NAD NAD NAD

– – – + –

– – – – –

– – Str+ – –

6.10 6.17 6.14 6.22 6.15

3.00 3.99 4.01 4.03 2.80

300 310 308 302 306

PE ( R PE(L) PE ( R PE ( R PE ( R

NAD

–

–

–

6.18

4.06

304

PE ( R )

NAD

NAD

–

–

–

5.14

2.85

103

PE ( R ) Kochs RUZ

NAD

NAD NAD

– –

– Adc+

– –

5.22 5.13

2.83 2.85

205 200

PE ( R ) PE(L)

Peri card effusion NAD

3min NAD 1min 40 alb++ sec ++ 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 2min 30 sc NAD 1 min 30 4 min sc NAD 1 min 30 2min 30 sc sc NAD 1 min 30 3min sc NAD 3min 1 min 30 NAD

) ) Consd ) )

Neph C, Asc NAD NAD NAD NAD

 CAS E RECOR DS 

3

36 37 38

80 79 88

96 20 48

6200 64 56 0 1 0 7200 67 38 0 2 0 8696 56 45 0 11 0

39 40

80 79

28 10

5626 61 56 1 6662 75 45 0

1 5

1 1

sc 1min 40 1 min 30 sec sc 3min 3min 3min 3min 1min 40 1min 40 sec sec 2min 30 sc 2min 30 sc

NAD NAD NAD

NAD NAD NAD

– – –

– – –

– – –

5.23 5.19 4.70

2.90 2.35 2.10

213 174 130

PE ( R ) PE(BL) PE(L) Kochs LUZ

NAD Crr, PHTN, Asc NAD

NAD NAD

NAD NAD

– –

– –

– –

4.73 4.80

2.50 2.90

162 143

PE ( R ) PE(BL)

NAD DCMP

 CAS E RECOR DS 

4

:: PART–C :: Sl. No

Colour

S p . G r.

Prote in (G%)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40

PY H T PY H PY PY PY H PY T PY PY PY PY PY H PY PY PY PY H PY PY PY PY H PY PY PY PY H PY PY PY PY T PY PY PY

1022 1012 1018 1022 1018 1022 1018 1018 1018 1018 1018 1022 1012 1010 1018 1012 1014 1018 1010 1019 1019 1020 1019 1018 1028 1018 1023 1010 1020 1023 1014 1014 1012 1012 1020 1010 1014 1014 1023 1017

3.00 4.29 4.30 4.23 4.33 4.3 4.28 4.27 4.24 3.00 4.21 4.33 4.29 4.22 4.18 4.24 4.52 3.00 4.50 4.48 4.41 4.45 4.18 4.63 4.69 2.70 2.70 2.71 2.73 2.75 2.38 2.76 2.38 2.42 2.41 2.42 2.41 1.92 1.98 1.94

Pleural Fluid Examination Cells LDH (U/L) Po Ly RBC 3.15 400 – F PL 3.20 95 – F – 3.19 408 – PL F 3.10 399 – F F 3.16 406 – PL – 3.12 408 – F – 3.17 409 – F – 3.21 410 – F PL 3.27 419 – PL F 3.22 415 – PL – 3.23 416 – F PL 3.41 406 – F – 3.17 418 – PL – 3.30 412 – F – 3.25 416 – PL – 3.15 419 – F – 3.17 660 – F PL 3.13 668 – PL F 3.19 677 – F – 3.25 673 – – – 3.23 495 – F – 3.21 680 – F F 3.27 98 – – – 4.06 573 P F – 4.04 577 – – – 3.20 450 – F PL 1.70 118 – F – 1.72 128 – F – 1.71 123 P F – 1.78 128 – F F 1.75 95 – F – 1.76 131 – F PL 1.29 98 – F – 1.27 95 – – – 1.30 73 – F PL 1.35 83 – F – 1.34 105 – F – 1.06 85 – F – 1.10 73 – F – 1.14 92 – F –

Albumin (mg%)

AFB

Im Cell

+

– – – AdC+ – – – AdC+ – – – – – – – – – – – – – AdC+ SqC+ – – – – – – – – – – – – – – – – –

+ – – – – – – – – – – – – + – – – – – – – – – – – – – – – – – – – – – – – –

Pyo. Organis m – – – – – – – – – – – – – – – – – – – – – – – Pyo. – – – – Pyo. – – – – – – – – – – –

Pleural Biopsy T. B . – T. B . – – – – – T. B . T. B . – – – – – – AdC+ – AdC+ – – – – – T. B . – – – – T. B . – NHL – – – T. B . – T. B . – –

Miscellaneous — — — C . T. s c a n – l u n g m a s s ( A d C + ) — — — C . T. s c a n – l u n g m a s s ( A d C + ) — Scl(L)FNAC TB C . T. s c a n – l u n g m a s s ( A d C + ) — Scl(L)FNAC TB RF +VE — — Lt cerv Node FNAC AdC+ — — — — — — — — — — — — Rt Cerv FNAC TB — Lt Scl Node FNAC NHL — — Lt. Sup sclav FNAC AdC+ — — — — —

 CAS E RECOR DS 

5